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Background: Antioxidants have been shown to enhance the proliferation of adipose-derived mesenchymal stem cells
(ADMSCs) in vitro, although the detailed mechanism(s) and potential side effects are not fully understood.
In this study, human ADMSCs cultured in ImF-A medium supplemented with antioxidants (N-acetyl-L-cysteine and
ascorbic acid-2-phosphate) and fibroblast growth factor 2 (FGF-2) were compared with ADMSCs cultured with FGF-2
alone (ImF) or with FGF-2 under 5% pO2 conditions (ImF-H).
Results: During log-phase growth, exposure to ImF-A resulted in a higher percentage of ADMSCs in the S phase of the
cell cycle and a smaller percentage in G0/G1 phase. This resulted in a significantly reduced cell-doubling time and
increased number of cells in the antioxidant-supplemented cultures compared with those supplemented with FGF-2
alone, an approximately 225% higher cell density after 7 days. Western blotting showed that the levels of the CDK
inhibitors p21 and p27 decreased after ImF-A treatment, whereas CDK2, CDK4, and CDC2 levels clearly increased. In
addition, ImF-A resulted in significant reduction in the expression of CD29, CD90, and CD105, whereas relative telomere
length, osteogenesis, adipogenesis, and chondrogenesis were enhanced. The results were similar for ADMSCs treated
with antioxidants and those under hypoxic conditions.
Conclusion: Antioxidant treatment promotes entry of ADMSCs into the S phase by suppressing cyclin-dependent
kinase inhibitors and results in rapid cell proliferation similar to that observed under hypoxic conditions.
Keywords: Adipose-derived mesenchymal stem cells, Antioxidant, Fibroblast growth factor-2, HypoxiaBackground
Human mesenchymal stem cells (MSCs) are emerging as
powerful tools in regenerative medicine. Clinical applica-
tions using MSCs have recently been reported for treating
acute diseases, such as acute myocardial infarction [1],
hemorrhagic stroke [2], and acute soft-tissue injuries [3].
To reduce patient waiting time, culture conditions are
needed for rapid and reproducible in vitro expansion of
MSCs. Current methods under development for obtaining
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reproduction in any medium, provided the orbioreactors [4-7], different types of serum [8,9], platelet ly-
sates [10], and growth factors [11].
Recently, hypoxia (1%–5% pO2) was also shown to en-
hance cell growth [12,13] and cell homing ability [14,15].
The osteogenic and chondrogenic potentials of bone mar-
row mesenchymal stem cells (BMMSCs) exposed to hyp-
oxic conditions were increased relative to those cultured
under normoxic conditions (approximately 21% pO2),
possibly via a hypoxic effect on the regulation of the cell
cycle [13]. Thus, it is possible that high oxygen environ-
ments, that increase the levels of reactive oxygen species
(ROS) through cellular respiration are not suitable for
large-scale production of high-quality MSCs in a stir sys-
tem. However, some studies have shown that a culture
medium with low calcium levels and supplemented with
antioxidants can accelerate the growth and prolong the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(ADMSCs) under normoxic conditions [16,17]. According
to these studies, the effects of antioxidants on cell expan-
sion of ADMSCs are similar to those of hypoxia on
BMMSCs. However, mechanism(s) by which antioxidants
exert these effects on ADMSCs remains unclear.
ADMSCs have recently been identified as more power-
ful tools for regenerative medicine than BMMSCs because
they can be expanded more rapidly [18,19], they secrete
cytokines and growth factors [20,21], and they can be
obtained in large numbers from liposuction aspirates
[16,22-24]. In addition, it has been suggested that fibro-
blast growth factor 2 (FGF-2) is the most effective factor
for promoting the growth of BMMSCs in vitro [11] and
that it enhances the osteogenic and chondrogenic poten-
tial of these cells [25,26]. We therefore hypothesized that,
compared with hypoxia, a combination of antioxidants
and FGF-2 may be a more rapid and easy method to con-
trol the culture of ADMSCs in vitro. We also speculated
that antioxidants may act through the same mechanism(s)
as hypoxia promotes MSC proliferation. Thus, in the
present study, we examined the effects of antioxidants and
FGF-2 on proliferation, cell cycle regulation, cell-surface
antigens, stemness-related gene expression, and differenti-
ation potential in comparison with a combination of either
normoxia and FGF-2 or hypoxia and FGF-2.
Methods
Isolation and maintenance of human ADMSCs
This study was approved by the Buddhist Tzu Chi General
Hospital Internal Review Board (IRB100-102). Stromal-
vascular fraction (SVF) cells were isolated using a method
modified from that described by Griesche and colleagues
[27]. Human adipose tissues were diluted 2-fold with
phosphate-buffered saline (PBS, GIBCO-Invitrogen), and
collagenase type I (final concentration: 0.4 mg/mL; Sigma)
was added for enzymatic digestion in a hybridization oven
(37°C, 30° angle, 15 rpm, 45 min; RH-800D, YIHDER).
Digested adipose tissues were centrifuged at 400 × g for
10 min to generate the SVF pellet, which was resuspended
in PBS and filtered through a 70-μm nylon mesh (Becton
Dickinson) to isolate SVF for subsequent ADMSCs culture.
Experiments were conducted using ADMSCs at passages
2 to 5. To maintain and expand ADMSCs populations, the
cells were cultured in MSC maintenance medium con-
taining Iscove’s modified Dulbecco’s medium (IMDM;
GIBCO-Invitrogen) and 10% fetal bovine serum (FBS,
MSC-Qualified, GIBCO-Invitrogen) with 10 ng/mL FGF-2
(R&D Systems) as described [6,7].
Culture of ADMSCs with antioxidants and FGF-2 under
normoxic or hypoxic conditions
Figure 1 shows a schematic diagram of the four culture
processes. For the experiments described herein, ADMSCswere seeded at an initial cell density of 3,000 cells/cm2 in
tissue culture flasks or 6-well plates (Becton Dickinson).
The normoxic environment was maintained at 37°C
in a humidified 5% pCO2 incubator (Forma Series II
Model 3110, Thermo), and the hypoxic environment was
maintained at 37°C in a humidified incubator (MCO-
18 M, Sanyo) containing 5% pO2 and 5% pCO2. The ex-
perimental group (ImF-A) was cultured in IMDM
supplemented with 10% FBS, 10 ng/mL FGF-2, 2 mMN-
acetyl-L-cysteine (NAC, Sigma), and 0.2 mM L-ascorbic
acid-2-phosphate (AsA2P, Sigma) in the normoxic envir-
onment. The positive control group was cultured in
IMDM supplemented with 10% FBS and 10 ng/mL FGF-2
in the hypoxic environment (ImF-H). The negative con-
trols were cultured in the normoxic environment with
(ImF) or without (Im) 10 ng/mL FGF-2. Starting on day 3,
the media were completely changed every 3 days for
all groups.
Cell proliferation and viability assays
For cell proliferation and viability assays, cells were de-
tached by trypsinization (GIBCO-Invitrogen) and use of
a cell scraper (Becton Dickinson). They were then
counted in triplicate using a cell counter (Vi-CELL AS,
Beckman Coulter). Cell viability was measured using
0.4% (w/v) trypan-blue (GIBCO-Invitrogen) exclusion
and software (Beckman Coulter) set to the parameter
values recommended for ADMSCs (100 images, 10–
30 μm, 75% spot brightness, 5% spot area). Doubling
time was calculated as = time/(3.32[log10Nt - log10N0]),
where Nt and N0 are the final and initial cell densities,
respectively.
Cell population and cell-surface antigen analysis
Antibodies against human CD13, CD14, CD29, CD34,
CD44, CD45, CD73, CD90, CD105, β2 microglobulin
(B2M), and HLA-DR were purchased from Becton
Dickinson. For the characterization of cell-surface anti-
gen phenotype, the ADMSCs were cultured in 75-cm2 tis-
sue culture flasks (Becton Dickinson) at an initial density of
3,000 cells/cm2 for 6 days. Cells were harvested and stained
with an antibody coupled to fluorescein isothiocyanate or
R-phycoerythrin, and then analyzed by flow cytometry
(FACSCalibur, Becton Dickinson). ADMSC populations
were assessed by their forward (size) and side (granularity)
scattering properties deduced by flow cytometry.Cell cycle analysis
For cell cycle analysis, 75-cm2 tissue culture flasks
seeded with ADMSCs (initial density, 3000 cells/cm2)
were placed in the aforementioned four culture environ-
ments for 3 days. Flasks (n = 3) were removed from the
incubator to detach and harvest the cells for cell cycle
Figure 1 Overview of ADMSCs culture conditions and assay design.
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ide (Sigma) staining and percentages of cells in each
phase of the cell cycle were analyzed by flow cytometry
and MultiCycle software (Phoenix Flow Systems).
Analyses of gene expression and telomere length
Isolation of total RNA, cDNA synthesis, and amplification
reactions were carried out as described [28]. Total RNA
was isolated from cells using the RNeasy kit (Qiagen), and
cDNA was synthesized from 10 μg of total RNA using the
Advantage RT-for-PCR kit (Clontech). The resulting cDNA
was subjected to PCR amplification using the gene-specific
primers listed in Table 1 to identify how the different cell
conditions affected the expression levels of p21 (cyclin-
dependent kinase inhibitor 1A), p27 (cyclin-dependent
kinase inhibitor 1B), Nanog, Oct4 (octamer-binding tran-
scription factor 4), SOX2 (sex-determining region Y-box 2),
CXCR4 (C-X-C chemokine receptor type 4), HIF1A (hyp-
oxia inducible factor 1, alpha subunit), VEGF (vascular
endothelial growth factor), TGF-β1 (transforming growth
factor beta 1), cbfa1 (core-binding factor subunit alpha-1),
OC (osteocalcin), PPARr (proliferator-activated receptor γ),
C/EBPα (CCAAT⁄enhancer-binding protein α), ACAN
(aggrecan), COL2A1 (collagen type II, alpha 1), and β-actin.
Gene expression levels were normalized to that of the
β-actin gene, which served as the internal control. The
relative telomere lengths of ADMSCs (from passage 2 to
passage 5) after 14 days under the four conditions were de-
termined using the telomere/single-gene ratio detected
using the method described by Cawthon [29]. DNA was
isolated using the QIAamp DNA mini kit (Qiagen). The
gene-specific primers are listed in Table 1. The amplified
genes included 36B4 and Telomeres. Quantitative PCR andproduct detection were performed using the Fast Start
Essential DNA Green Master (Roche) and the PikoReal
Real-Time PCR System (Thermo Scientific), and analyzed
using PikoReal 2.0 software (Thermo Scientific).
Western blot analysis
These procedures were modified from that described by
Chiu et al. [30]. Cells were detached using a cell scraper
and then resuspended in lysis buffer (50 mM Tris-HCl,
pH 7.5, 0.5 M NaCl, 5 mM MgCl2, 0.5% Nonidet P-40,
1 mM phenylmethylsulfonyl fluoride, 1 μg/mL pep-
statin, and 50 μg/mL leupeptin) on ice and centrifuged
at 13,000 × g at 4°C for 30 min. Protein (20 μg) was col-
lected, subjected to 10% SDS-PAGE, and transferred to
a polyvinylidene difluoride membrane blocked with 5%
non-fat milk in Tris-buffered saline containing 0.1%
Tween 20 for 1 h at room temperature. The various mem-
branes were probed with appropriate dilutions of the fol-
lowing primary antibodies at 4°C overnight: cyclin A2,
cyclin D1, cyclin D3, p21, p27, cyclin-dependent kinase
(CDK) 2, CDK4, CDK6, and cell division control protein 2
(CDC2) (Cell Signaling Technology). After the membranes
were washed three times with Tris-buffered saline (0.1%
Tween 20), they were incubated with a horseradish perox-
idase–conjugated secondary antibody (anti-mouse or anti-
rabbit, Cell Signaling Technology) for 1 h at room
temperature. All resolved protein bands were analyzed
with ImageJ 1.40 g software (NIH).
In vitro differentiation analysis
Osteogenesis and adipogenesis were induced using
established protocols [6]. ADMSCs recovered from Im,
ImF, ImF-H, and ImF-A at day 6 were re-plated onto





β-actin S: 5′-CGCCAACCGCGAGAAGAT-3′ 168
A: 5′-CGTCACCGGAGTCCATCA-3′
P21 S: 5′-CCGAAGTCAGTTCCTTGTGG-3′ 112
A: 5′-CATGGGTTCTGACGGACAT-3′
P27 S: 5′-TTTGACTTGCATGAAGAGAAGC-3′ 84
A: 5′-AGCTGTCTCTGAAAGGGACATT-3′
Nanog S: 5′-AATACCTCAGCCTCCAGCAGAT-3′ 148
A: 5′-TGCGTCACACCATTGCTATTCTT-3′
Oct4 S: 5′-CTTGCTGCAGAAGTGGGTGGAGGAA-3′ 187
A: 5′-CTGCAGTGTGGGTTTCGGGCA-3′
SOX9 S: 5′-AGACCAGTACCCGCATCT-3′ 108
A: 5′-CGCTCCGCCTCCTCCAC-3′
CXCR4 S: 5′-CGTGGAACGTTTTTCCTGTT-3′ 129
A: 5′-TGTAGGTGCTGAAATCAACCC-3′
HIF1A S: 5′-CAGCAACTTGAGGAAGTACC-3′ 139
A: 5′-CAGGGTCAGCACTACTTCG-3′
VEGF S: 5′-ACGATCGATACAGAAACCACG-3′ 105
A: 5′-CTCTGCGCAGAGTCTCCTCT-3′
TGF-β1 S: 5′-TAAATACAGCCCCCATGGCA-3′ 243
A: 5′-GTCCTGGCCCTGTACAACC-3′
Cbfa1 S: 5′-TGGCAGCACGCTATTAAATC-3′ 103
A: 5′-TCTGCCGCTAGAATTCAAAA-3′
OC S: 5′-CAAAGTCTAACTAGGGATACC-3′ 150
A: 5′-AGAGATGAGTCTGTCCTG-3′
PPARγ S: 5′-TTGCTGTCATTATTCTCAGTGGA-3′ 124
A: 5′-GAGGACTCAGGGTGGTTCAG-3′
CEBPα S: 5′-GACATCAGCGCCTACATCG-3′ 70
A: 5′-GGCTGTGCTGGAACAGGT-3′
ACAN S: 5′-TACACTGGCGAGCACTGTAAC-3′ 71
A: 5′- CAGTGGCCCTGGTACTTGTT-3′
COL2A1 S: 5′- GAATAGCACCATTGTGTAGGAC-3′ 97
A: 5′- AATGCCCCCTGAGTGAC-3′







S: sense, A: antisense.
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and osteogenic differentiation potential was evaluated
using alkaline phosphatase staining and cbfa1 and OC
expression at day 14. The adipogenic differentiation
potential of ADMSCs was evaluated using Oil red Ostaining and PPARγ and C/EBPα expression at day 7.
Methods for alkaline phosphatase staining and Oil red O
staining were previously reported [6,7].
Chondrogenesis was induced using chondrogenic
medium and the micromass culture method [17] con-
sisting of 1 × 105 cells/10 μl in 24-well plates for 2 hours
and then incubated in chondrogenic medium. Chon-
drogenic medium consisted of high-glucose DMEM
(Sigma), supplemented with ITS + premix (Sigma),
10 ng/mL transforming growth factor β1 (R&D),
100 μg/mL sodium pyruvate (Sigma), 50 μg/ml ascorbic
acid (Sigma), and 0.1 μM dexamethasone (Sigma). The
chondrogenic differentiation potential was evaluated
by using Alcian Blue (Sigma) staining of sulfated
proteoglycan-rich matrix (blue colour) and ACAN and
COL2A1 expression at day 14.
Statistical analyses
Statistical analyses for cell proliferation, cell population
characterization, cell cycle phase analysis, and gene
expression in each group were performed using the
Microsoft Excel data analysis program t-test, and
P values < 0.05 were considered statistically significant.
Experiments were performed at least twice, and each
value represents the mean ± SD (n = 3 for replicates).
Results
Effects of antioxidants and FGF-2 on ADMSC proliferation
As shown in Figure 2A and Table 2, cell density signifi-
cantly differed between ADMSCs grown in Im and those
grown in ImF after 2 days. There was an approximately
1.2-fold decrease in the log-phase doubling time in the
ImF cultures (Table 2). Similarly, there was an approxi-
mately 3.3-fold increase in the number of cells obtained
from the ImF cultures after 7 days. As shown in Figure 2B
and Table 2, the doubling time of ADMSCs was decreased
relative to ImF culture after ImF-A or ImF-H culture. In
addition, there were significant fold differences in cell
densities and log-phase doubling time between ImF-A
group and the respective control groups (Im and ImF),
with approximately 225%–740% higher cell densities after
7 days in culture.
To investigate the effect of the combination of antioxi-
dants and FGF-2 on cellular aging, relative telomere
lengths of ADMSCs after 14 days under the four condi-
tions were determined from the telomere/single gene ra-
tio. As shown in Figure 2C, telomeres were relatively
longer in ADMSCs in the ImF-A and ImF-H groups rela-
tive to the ImF group.
Effects of antioxidants and FGF-2 on cell cycle regulation
To further investigate the mechanism(s) underlying the
stimulation of proliferation by antioxidants, we used
flow cytometry analysis in conjunction with propidium
Figure 2 Effects of FGF-2 and antioxidants on ADMSCs proliferation under normoxic or hypoxic conditions. (A) Cell density in the
presence (ImF) or absence (Im) of FGF-2. (B) Cell density in the presence of FGF-2 (ImF), FGF-2 with antioxidants (ImF-A), or FGF-2 under hypoxic
conditions (ImF-H). (C) Relative telomere length of ADMSCs after 14 days under the four culture conditions as assessed by quantitative PCR. Medium
was changed every 3 days, starting on the third day. Each bar represents the mean value ± SD (n = 3). * P < 0.05. ** P < 0.01. *** P < 0.005.
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in various cell cycle stages (Figure 3A). Significant differ-
ences were observed between ADMSCs cultured in ImF-
A and ImF-H relative to the control groups (Im and
ImF) at day 3 (during log-phase growth), at which time
exposure to both antioxidants and hypoxia resulted in a
greater percentage of cells in the S phase and a smaller
percentage in the G0/G1 phase.
In addition, reverse transcription quantitative PCR (RT-
qPCR) analysis (Figure 3B) showed that expression of the
CDK inhibitors p21 and p27 decreased after FGF-2 treat-
ment. Western blot analysis (Figure 3C) showed that levels
of the CDK inhibitors p21 and p27 also decreased in the
antioxidant-treated cells (ImF-A), although CDK2, CDK4,
and CDC2 levels clearly increased. Similar results were
obtained with hypoxia-treated cells (ImF-H), although the
extent of change from the control group (ImF) was
smaller than that with antioxidant treatment.Effects of antioxidants and FGF-2 on stemness-related
gene expression
RT-qPCR analysis showed that FGF-2 enhanced the ex-
pression of genes, including Nanog, Oct4, SOX2, CXCR4,
HIF1A, and VEGF (Figure 4). However, ImF-A or ImF-H
decreased the expression of Nanog, SOX2, CXCR4
and TGF-β1. Moreover, the expression of Nanog, Oct4,Table 2 Effects of different cell culturing methods on
growth kinetic parameters
Cell type Conditions Fold increase
in cell density (7 days)
# Doubling
time (h)
ADMSC Im 8.6 28.6 ± 4.9
ImF a 28.4 22.6 ± 3.4
ImF-H a,b 44.7 17.8 ± 6.1
ImF-A a,b,c 63.8 a,b 13.1 ± 1.0
P < 0.05, avs. Im, bvs. ImF, cvs. ImF-H.
#Doubling time represents the minimal doubling time during log phase.CXCR4, HIF1A, and VEGF was significantly lower in the
ImF-H group than in the ImF-A group.
Effects of antioxidants and FGF-2 on cell morphology, cell
populations, and immunophenotypes
As shown in Figure 5A, when FGF-2 was added to the
medium (ImF, ImF-H, ImF-A), ADMSCs maintained their
spindle-shaped morphology. The size and granularity of
ADMSCs under the different culture conditions were also
assayed by their forward-and side-scatter properties as
assessed using flow cytometry (Figure 5B). Compared with
the Im group, the percentage of agranular cells (A1 quad-
rant) in the FGF-2 groups (ImF, ImF-H, ImF-A) increased
after 6 days in culture. The percentage of granular cells
(A2 quadrant) in the ImF-H group was substantially
higher than that in the normoxic environment (ImF and
ImF-A; approximately 20% pO2).
In addition, flow cytometry analysis of ADMSC immu-
nophenotypes showed that FGF-2 treatment for 6 days
resulted in significant reductions in CD105 (endoglin) ex-
pression (Table 3). However, CD29 (integrin β1, fibronectin
receptor) and CD105 expression decreased more in the
cells treated with ImF-A than in those treated with ImF-H
for 6 days. The effects of these treatments on CD105 were
further confirmed in the EdU-labeled cells experiments:
Additional file 1: Figure S1 showed that FGF-2, hypoxia,
and antioxidants all resulted in higher percentage of EdU-
labeled ADMSCs of low CD105 expression (F4 division),
but the reductions of CD105 were also found in non-
proliferated cells (F1, EdU-negative cells).
Effects of antioxidants and FGF-2 on the differentiation
potential of ADMSCs
As shown in Figure 6A-6C, ADMSCs that had undergone
the different treatments could differentiate into osteo-
blasts, chondrocytes, or adipocytes. RT-qPCR analysis
showed that osteo-differentiated ADMSCs from the ImF-
A group expressed higher levels of cbfa1 and OC than
Figure 3 Effects of FGF-2, antioxidants, and hypoxia on the cell cycle profiles of ADMSCs. (A) The percentage of cells in each phase of the
cell cycle at day 3. (B) Relative levels of p21 and p27 mRNAs in ADMSCs from the various culture conditions. Expression of β-actin served as the
internal control. Expression values were normalized to the corresponding values measured for cells cultured under the Im condition. (C) Western
blot analysis showed that CDK4 increased, but p21 and p27 decreased, in cells cultured under ImF-H or ImF-A conditions. (D) Schematic diagram
of antioxidant effects on cell cycle progression. The bars represent the mean value ± SD (n = 3). * P < 0.05. ** P < 0.01. *** P < 0.005.
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Figure 4 Changes in expression of growth factor and stemness genes under the different culture conditions. (A) Relative expression levels
of two growth factor genes in ADMSCs from the four different conditions. (B) Relative expression levels of stemness genes in ADMSCs from the four
different conditions. Expression of β-actin served as the internal control. The gene expression ratios were normalized to the corresponding levels
measured for cells cultured under the Im condition. Each bar represents the mean value ± SD (n = 3). * P < 0.05. ** P < 0.01. *** P < 0.005.
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differentiated ADMSCs from the ImF-A group expressed
higher levels of ACAN and COL2A1 than cells from the
Im and ImF groups (Figure 6F). After antioxidant treat-
ment, adipo-differentiated ADMSCs also expressed higher
levels of PPARγ and C/EPBα than cells from the Im
and ImF groups (Figure 6E), and the number of Oil Red
O-positive lipid vacuoles was increased in these cells. AsFigure 5 Effects of different conditions on the morphology and cell p
Bar = 500 μm. (B) Changes in cell size and granularity of ADMSCs as charac
derived from flow cytometry. The density plots are divided into four quadr
between 1 and 5 are colored from blue (least dense) to red (most dense).indicated in Figure 6D-6F, our data suggest that FGF-2
enhances the osteogenic, chondrogenic, and adipogenic
differentiation potential of ADMSCs and a combination
of antioxidants and FGF-2 further enhances this poten-
tial. However, the changes in expression of osteogenic,
chondrogenic and adipogenic genes that were observed
in the ImF-A group after 6 days exposure were similar
to that observed in the ImF-H group.opulation of ADMSCs. (A) Photomicrographs of ADMSCs.
terized by forward-scatter (FS) versus side-scatter (SS) density plots
ants (A1–A4). The density threshold is 50 cells, and density levels
Table 3 Effect of the four culture conditions on ADSC
surface markers
Surface marker Im ImF ImF-H ImF-A
CD13 +++ +++ +++ +++
CD14 - - - -
CD29 +++ +++ ++ ++
CD34 - - - -
CD44 +++ +++ +++ +++
CD45 - - - -
CD73 +++ +++ +++ +++
CD90 +++ +++ ++ ++
CD105 +++ ++ ++ +
B2M +++ +++ ++ ++
HLA-DR -+ - - -
-: 0 ~ 5%; -+:5 ~ 25%; +:25 ~ 50%; ++: 50 ~ 95%; +++: 95 ~ 100%.
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The detailed mechanisms by which antioxidants induce
cell proliferation remain unclear, although the effects of
antioxidants on ADMSC growth have been examined by
some investigators [16,17,31]. In this study, we observed
that both hypoxia and antioxidants increased ADMSC
proliferation by increasing the number of cells in the
S phase, but the maximal increase in cell number was
obtained in the presence of antioxidants (Figure 2B and
Additional file 2: Figure S2). As shown in Additional file 3:
Figure S3, NAC alone (ImF-Nac), AsA2P alone (ImF-
AsA2P), or NAC+AsA2P (ImF-A) all resulted in higher
cell proliferation as compared to the control medium
(ImF). We also found that exposure to antioxidants and
FGF-2 stimulated the proliferation of MSCs obtained from
adult human liposuction aspirates (Figure 2B), bone mar-
row and Wharton's jelly (Additional file 4: Figure S4).
Antioxidants [32] and hypoxia [33] are believed to
decrease intracellular ROS levels, and intracellular
ROS play key roles in regulating cell adhesion and cell
proliferation [34]. Hypoxia is also known to affect the se-
cretion of several growth factors [13,33], such as insulin-
like growth factor, VEGF, hepatocyte growth factor, HIF,
and FGF-2, which have been shown to accelerate the ex-
pansion of BMMSCs [11]. However, HIF1A can enhance
hepatocyte growth factor and FGF-2 secretion from
MSCs [33], and TGF-β1 can inhibit the proliferation of
human prostatic epithelial cells by upregulating the
levels of p15, p21, and p27 and by arresting the cell cycle
in the G1 phase [35]. Recently, Tsai et al. reported that
MSCs cultured under hypoxia can increase expansion,
bypass cellular senescence, and maintain stem cell prop-
erties by increasing the proportion of cells in the S phase
and suppressing E2A-p21 expression through the HIF-
TWIST pathway [36]. In this study, HIF1A and VEGF
were significantly upregulated in the ImF, ImF-H,and ImF-A groups, whereas TGF-β1 was significantly
downregulated (Figure 4B and Additional file 5: Figure
S5). Therefore, it is possible that the ImF-A-treated or
ImF-H-treated cells switched on their cell cycle program
through autocrine and paracrine effects via a similar path-
way. This hypothesis is further supported by the results of
our western blot analysis (Figure 3C) that showed similar
cell cycle-associated regulator profiles in Figure 3C be-
tween the ImF-A and ImF-H treatments. Most interest-
ingly, addition of antioxidants also suppressed the cellular
reactive oxygen species (ROS) and restored cell prolifera-
tion of ADMSCs under hyperoxia (37.5% pO2, Additional
file 6: Figure S6A-6C). The suppression of ROS and res-
toration of cell growth by antioxidants were associated
with the restoration of p21 and CDK2 in western blot ana-
lysis (Additional file 6: Figure S6D).
Some studies have found that the expression of CD90
and CD105 was lower in hypoxia-expanded MSCs than in
normoxia-expanded MSCs [37,38]. In this study, we ob-
served that ADMSCs are positive for the cell-surface
markers CD13, CD29, CD44, CD73, CD90, CD105, and
B2M and negative for CD14, CD34, CD45, CD235a, and
HLA-DR; however, the degree of expression of some of
these markers varied depending on the culture conditions.
We also found that both antioxidants and hypoxia de-
creased the expression of CD29 (integrin β1; fibronectin
receptor), CD90 (Thy-1; cell-matrix interactions), CD105
(endoglin; matrix protein), and B2M (a component of
MHC class I molecules). Hypoxia promotes MSCs migra-
tion [13,39] and their mobilization into the peripheral
blood [40]. However, the decreased expression of CD29,
CD90, and CD105 by these cells in the ImF-H and ImF-A
groups may be associated with changes in cell migration
or cell-matrix interactions. This hypothesis is supported
by our observation that cell surface antigen profiles were
similar in the ImF-A and ImF-H groups.
We also found that antioxidants affect the expression
levels of stemness genes (Figure 4) and the differentiation
potential (Figure 6) of ADMSCs. The expression of Oct4,
Nanog, SOX2, and CXCR4 was higher under hypoxic con-
dition than under normoxic conditions (Additional file 7:
Figure S7), similar to the results of previous studies
[13-15,31]. In our experiments, stemness genes were sig-
nificantly upregulated when FGF-2 was added to the
medium, but the expression levels of Nanog, Oct4, and
CXCR4 were higher in the ImF-A group than in the ImF-
H group. Hypoxia can enhance the osteogenic potential of
BMMSCs, although it also inhibits their adipogenic poten-
tial [12,13]. When the accumulation of intracellular ROS
in BMMSCs was inhibited by NAC, the adipogenic differ-
entiation of BMMSCs was also inhibited [32]. FGF-2 also
enhances the osteogenic [11], chondrogenic [26], and
adipogenic potential [41] of ADMSCs. In the present
study, we also observed differences in the differentiation
Figure 6 Differentiation potential of ADMSCs after 6 days under the four culture conditions. (A) Photomicrographs showing alkaline
phosphatase activity of ADMSCs after 14 days osteo-differentiation. Bar = 500 μm. (B) Photomicrographs of lipid spheres in ADMSCs after 7 days adipo-
differentiation. Lipid spheres were visualized by Oil Red O staining. Bar = 500 μm. (C) Photomicrographs of sulfated proteoglycan-rich matrix (blue color) in
ADMSCs after 14 days chondro -differentiation. (D) Quantification of osteogenic mRNA in ADMSCs after 14 days osteo-differentiation. (E) Quantification of
adipogenic mRNA in ADMSCs after 7 days adipo-differentiation. (F) Quantification of chondrogenic mRNA in ADMSCs after 7 days adipo-differentiation.
Expression of β-actin served as the internal control. Each bar represents the mean value ± SD (n = 3). * P< 0.05. ** P< 0.01. *** P< 0.005.
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ADMSCs exposed to FGF-2 had relatively greater differen-
tiation potential; however, this potential was greatly en-
hanced in cells treated with ImF-H or ImF-A.
Conclusions
We infer that antioxidants can modulate the cell cycle
progression of ADMSCs by downregulating CDK and
CDK4 inhibitors and upregulating CDK2, CDK4, and
CDC2 expression. In the presence of antioxidants andFGF-2, ADMSCs rapidly proliferate and retain their
stem cell properties, and their osteogenic and adipogenic
potentials are enhanced. The mechanisms by which anti-
oxidants induce cell proliferation are possibly the same
as those involved in hypoxia, but the in vitro culture en-
vironment of antioxidant-supplemented medium under
normoxic conditions may be more stable than hypoxic
conditions. Thus, we propose that a combination of anti-
oxidants and FGF-2 under normoxic conditions may
provide an easy and rapid method for in vitro expansion
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http://www.jbiomedsci.com/content/20/1/53of both ADMSCs and BMMSCs. Further development
of this method for culturing MSCs in bioreactors may
provide more functional MSCs for cell therapy and re-
duce patient waiting time without compromising the
capacity of these cells to differentiate.
Additional files
Additional file 1: Figure S1. Effects of FGF-2, antioxidants and different
oxygen partial pressure on the expressions of CD105 in ADMSCs. The
proliferated ADMSCs were labeled with EdU (5-ethynyl-2′-deoxyuridine)
by cultured in medium with 5 μM EdU overnight as recommended by
the manufacturer (Click-iT® EdU Alexa Fluor® 488 Flow Cytometry Assay
Kit, Molecular Probes). CD105 expression and the percentage of
EdU-labeled ADMSCs were measured by flow cytometry. In the negative
control experiment, the ADMSCs were cultured under the same
conditions without EdU. Density level threshold, 50 cells, and density
levels of 1–5 indicated by color (blue to red).
Additional file 2: Figure S2. Effects of antioxidants on ADMSCs
proliferation under normoxic or hypoxic conditions. ADMSCs were cultured
in Im, Im-H (hypoxia), and Im-A (containing antioxidants: NAC and AsA2P) at
an initial cell density of 3,000 cells/cm2, respectively. Medium was changed
every 3 days, starting at day 3. Each bar represents the mean value ± SD
(n = 3). * P < 0.05.
Additional file 3: Figure S3. Effects of different antioxidants on
ADMSCs (A) proliferation and (B) cell cycle-regulated proteins.
Additional file 4: Figure S4. Effects of antioxidants on different type of
MSCs under normoxic or hypoxic conditions. (A) Adipose-derived
mesenchymal stem cells (ADMSCs). (B) Bone marrow mesenchymal stem
cells (BMMSCs). (C) Wharton’s jelly stem cells (WJSCs). Medium was
changed every 3 days, starting at day 3. Each bar represents the mean
value ± SD (n = 3). * P < 0.05.
Additional file 5: Figure S5. Effects of antioxidants and hypoxic
condition on HIF-1α expression in ADMSCs. Expression of β-actin served
as the internal control. The relative expressions were expressed as fold
induction as compared to ImF.
Additional file 6: Figure S6. Effects of antioxidants and different
oxygen partial pressure on cellular H2O2 and cell proliferation of ADMSCs.
(A) ROS level of ADMSCs cultured under normoxia with/without
antioxidant or under hypoxia (5% pO2) on Day 5. (B) ROS level of
ADMSCs cultured under normoxia or under hyperoxia (37.5% pO2) with/
without antioxidant on Day 5. (C) Proliferation of ADMSCs cultured under
normoxia with/without antioxidant (ImF / ImF-A) or under hyperoxia
with/without antioxidant (ImF(37.5% pO2) / ImF-A(37.5% pO2)).
(D) Western blot analysis of p21, CDK2 expressions on Day 5.
Additional file 7: Figure S7. Effects of hypoxia or antioxidants on
stemness genes expression in ADMSCs without FGF-2. Expression of β-actin
served as the internal control. The expression values were normalized to the
corresponding gene measured in cells cultured in medium alone. Each bar
represents the mean value ± SD (n = 3). * P < 0.05.
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